Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
Crossref DOI link: https://doi.org/10.1007/s40256-015-0157-9
Published Online: 2016-01-09
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vakkalagadda, Blisse
Frost, Charles
Byon, Wonkyung
Boyd, Rebecca A.
Wang, Jessie
Zhang, Donglu
Yu, Zhigang
Dias, Clapton
Shenker, Andrew
LaCreta, Frank
Funding for this research was provided by:
Bristol-Myers Squibb
Pfizer
Text and Data Mining valid from 2016-01-09